CRP and infection: Favorable outcomes were shown in patients without concomitant infections (n = 148, χ2 = 7.948, p = 0.005), with a completely normalized CRP value (n = 96, χ2 = 5.410; p = 0.02) and in patients who received antibiotic therapy over a period of more than six weeks (n = 91 or 38.4%, Corr = −0.159, χ2 = 5.733 p = 0.017).